BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 3452528)

  • 1. [Clinicopathologic analysis of 487 thyroid tumors].
    Cao XX; Gao LX; Wu X; Sha WX; Deng YJ
    Zhonghua Zhong Liu Za Zhi; 1987 Sep; 9(5):362-4, 19. PubMed ID: 3452528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinico pathologic analysis of 1503 thyroid tumors].
    Zhang JZ
    Zhonghua Zhong Liu Za Zhi; 1992 Nov; 13(6):470-2. PubMed ID: 1576917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients.
    Volante M; Landolfi S; Chiusa L; Palestini N; Motta M; Codegone A; Torchio B; Papotti MG
    Cancer; 2004 Mar; 100(5):950-7. PubMed ID: 14983490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid papillary carcinoma of columnar cell type: a clinicopathologic study of 16 cases.
    Wenig BM; Thompson LD; Adair CF; Shmookler B; Heffess CS
    Cancer; 1998 Feb; 82(4):740-53. PubMed ID: 9477108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
    Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
    Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathology of thyroid carcinoma. A review of 500 cases.
    Taşcă C
    Morphol Embryol (Bucur); 1978; 24(4):331-6. PubMed ID: 155200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Morphologic and molecular-genetic characteristics of carcinoma, adenoma and surrounding tissue of the thyroid gland].
    Pal'tsev MA; Kogan EA; Tuntsova OI; Severin ES; Silaeva SA; Golenchenko VA
    Arkh Patol; 1998; 60(3):5-10. PubMed ID: 9702292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
    Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
    Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential (Ha-, K- and N-) ras p21 expression in benign and malignant human thyroid tumors: an immunohistochemical study.
    Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Nakamura S; Hashimoto T
    Anticancer Res; 1995; 15(3):755-9. PubMed ID: 7645954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy.
    Máximo V; Lima J; Soares P; Botelho T; Gomes L; Sobrinho-Simões M
    Mitochondrion; 2005 Oct; 5(5):333-40. PubMed ID: 16183030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of accordance between cytological and histopathological findings in selected thyroid tumors].
    Gołkowski F; Jabrocka A; Huszno B; Trofimiuk M; Buziak-Bereza M; Kulig J; Cichoń S
    Przegl Lek; 2004; 61(1):10-2. PubMed ID: 15230098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
    Gemsenjäger E; Heitz PU; Martina B; Schweizer I
    Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity and specificity of fine needle aspiration cytology in the diagnosis of tumors of the thyroid gland.
    Akerman M; Tennvall J; Biörklund A; Mårtensson H; Möller T
    Acta Cytol; 1985; 29(5):850-5. PubMed ID: 3863433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
    Furlan JC; Bedard YC; Rosen IB
    J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions.
    Brzeziańska E; Cyniak-Magierska A; Sporny S; Pastuszak-Lewandoska D; Lewiński A
    Neuro Endocrinol Lett; 2007 Aug; 28(4):341-50. PubMed ID: 17693985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study of type-1 blood antigen expressions in thyroid tumors: the significance for papillary carcinomas.
    Kamoshida S; Ogane N; Yasuda M; Muramatsu T; Bessho T; Kajiwara H; Osamura RY
    Mod Pathol; 2000 Jul; 13(7):736-41. PubMed ID: 10912932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
    Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
    Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-cell hyperplasia accompanying thyroid diseases other than medullary carcinoma: an immunocytochemical study by means of antibodies to calcitonin and somatostatin.
    Scopsi L; Di Palma S; Ferrari C; Holst JJ; Rehfeld JF; Rilke F
    Mod Pathol; 1991 May; 4(3):297-304. PubMed ID: 1676840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unilateral lobectomy for Hurthle cell adenoma.
    Wasvary H; Czako P; Poulik J; Lucas R
    Am Surg; 1998 Aug; 64(8):729-32; discussion 732-3. PubMed ID: 9697901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.